The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

Polyp recurrence occurred in more than 1 in 3 patients with chronic rhinosinusitis with nasal polyps who underwent endoscopic sinus surgery, with several prognostic factors linked with recurrence.

Please provide your email address to receive an email when new articles are posted on . Wenyi Chen, of the department of otolaryngology-head and neck surgery at Third Affiliated Hospital of Sun ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Reduced health-related quality of life was identified in patients with chronic rhinosinusitis with nasal polyps compared with the general population—regardless of previous sinus surgery or presence of ...

In patients with chronic rhinosinusitis with nasal polyps, add-on mepolizumab (Nucala) reduced both polyp size and the need for surgery in the SYNAPSE study, a researcher reported. In the 52-week, ...

Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients with severe chronic rhinosinusitis with nasal polyps who received mepolizumab ...

A study of the nasal microbiome helped researchers predict recurrent polyps in chronic rhinosinusitis patients with more than 90% accuracy, based on data from 85 individuals. Chronic rhinosinusitis ...

The authors utilized medical and pharmacy claims obtained from the Optum Clinformatics Data Mart Database. Among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), younger age, elevated ...

Dear Dr. Roach: I have suffered from asthma and nasal polyps for more than 20 years. The asthma is controlled, and I mention it only because it might have some connection with my polyps. The polyps ...

Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people worldwide, or about 12% of the population. Defined as a long-lasting ...